Search

Home > BioCentury This Week > What's Next for BIO, Plus: Pfizer, GSK
Podcast: BioCentury This Week
Episode:

What's Next for BIO, Plus: Pfizer, GSK

Category: Science & Medicine
Duration: 00:20:57
Publish Date: 2022-11-07 23:00:00
Description:

 BIO needs to pick a leadership team rather than a leader to give the trade group all the skills it needs moving forward, Washington Editor Steve Usdin said on the latest BioCentury This Week podcast. Usdin and Editor in Chief Simone Fishburn discuss how BIO needs to address the challenges it now faces, as well as the results of BioCentury’s industry-wide survey on the state of the trade group.
BioCentury’s podcast team also assess the latest developments in RSV product development, the infectious disease pipelines of Pfizer and GlaxoSmithKline, and top takeaways from Fishburn’s conversation on The BioCentury Show with Andy Plump, who is president of R&D at Takeda 

Total Play: 0